3 syllables: Pra, zo, sin. Stress on Pra.
PRAY-zoh-sin
/ˈpreɪ.zoʊ.sɪn/
Prazosin is pronounced PRAY-zoh-sin (/ˈpreɪ.zoʊ.sɪn/). It has three syllables (Pra-zo-sin), with the stress on "Pra". Prazosin is a prescription medication that blocks alpha-1 receptors to lower blood pressure and treat symptoms of anxiety or PTSD–related agitation. It’s a proper noun in medical contexts and is pronounced with emphasis on the first syllable. In clinical usage, it’s spoken quickly and with careful vowel quality to avoid mispronunciations that resemble similar-sounding drugs.
nounPrazosin is a prescription medication that blocks alpha-1 receptors to lower blood pressure and treat symptoms of anxiety or PTSD–related agitation. It’s a proper noun in medical contexts and is pronounced with emphasis on the first syllable. In clinical usage, it’s spoken quickly and with careful vowel quality to avoid mispronunciations that resemble similar-sounding drugs.
"The clinician prescribed prazosin to help manage nocturnal hypertension."
"She studied the pharmacology of prazosin for her pharmacotherapy exam."
"Prazosin is often started at a low dose and titrated up based on patient response."
Say PRAHY-zə-sin. The primary stress is on the first syllable: /ˈpreɪ.zəˌsɪn/. The middle syllable contains a schwa /ə/, and the final syllable is /sɪn/ or /sən/ in fast speech. In UK/US accents, you’ll keep /preɪ/ as in pray, then /zə/ as a weak vowel, ending with /sɪn/. Audio references: standard dictionaries and medical pronunciation guides align with /ˈpreɪ.zəˌsɪn/; try saying it slowly at first, then link the final consonant to form ‘-sin.’
Common errors: 1) Pronouncing the middle as a full vowel like /i/ or /iː/ (PRAY-zEE-sin) instead of the neutral /zə/. 2) Misplacing the primary stress on the second syllable (pre-ZO-sin) or the third (prez-O-sin). 3) Slurring the final /n/ or dropping it in fast speech. Corrections: keep the middle as /zə/ with a light schwa, place primary stress on the first syllable, and enunciate the final /n/ clearly: /ˈpreɪ.zəˌsɪn/.
US: /ˈpreɪ.zəˌsɪn/ with rhoticity affecting only the preceding vowel; UK: /ˈpreɪ.zəˌsɒn/ with a shorter final vowel and potential /ɒ/ in some speakers; AU: /ˈpreɪ.zəˌsɪn/ similar to US but with Australian vowel quality, often more centralized and less rhotic influence. Overall, the middle /zə/ tends to be a weak syllable; final /sɪn/ can be realized as /sən/ in rapid speech. Focus on keeping /ˈpreɪ/ intact and tapering the middle to a schwa to avoid mispronouncing as /ˈpreɪ.zɔːn/ or similar.” ,
Two main challenges: the combination of /preɪ/ with a dense /zə/ cluster and the final /sɪn/ syllable, which can slide to /sən/ in connected speech. Speakers often misplace stress or over-articulate the middle vowel, turning /zə/ into /ziː/ or /zo/. The fast medical narration can hide the schwa, making the word sound like one syllable. Focusing on deliberate, segmented practice with slow-to-fast progression helps stabilize the rhythm and prevents slurring.
Prazosin has no silent letters in standard medical pronunciation. The most consistent elements are the clearly enunciated /ˈpreɪ/ and final /sɪn/. Some rapid or accented speech may reduce the middle /ə/ toward a weaker vowel, but it remains audible as /zə/. In dense clinical narration, you’ll often hear a slightly faster, more compressed /ˈpreɪ.zən/ if the final /sɪn/ is elided in patient notes; however, the standard, pronunciation is /ˈpreɪ.zəˌsɪn/.
🗣️ Voice search tip: These questions are optimized for voice search. Try asking your voice assistant any of these questions about "Prazosin"!
US/UK/AU: • Vowel shifts: US /ˈpreɪ.zəˌsɪn/ with a clearer final vowel; UK /ˈpreɪ.zəˌsɒn/ may have a shorter middle and darker final; AU /ˈpreɪ.zəˌsɪn/ similar to US, but vowels may be more centralized. • Rhoticity: US and AU are rhotic; UK may be non-rhotic in some dialects, but here the word’s vowels don’t change drastically with rhoticity. • Consonants: emphasize the /z/ between syllables and keep /n/ crisp. • IPA references: US /ˈpreɪ.zəˌsɪn/, UK /ˈpreɪ.zəˌsɒn/, AU /ˈpreɪ.zəˌsɪn/.
Prazosin derives from the chemical naming conventions for adrenergic receptor blockers. It is a synthetic sympatholytic agent developed in the late 20th century for antihypertensive use and PTSD-associated symptoms. The root prazos- traces to the nitrogen-containing heterocycles used in pharmaceutical naming, while -osin is a common pharmacological suffix indicating a drug that affects receptor activity, particularly in the adrenergic system. First used in the literature in the 1980s as prazosin from its parent molecule, the compound was marketed to target alpha-1 receptors. The term evolved in clinical practice to denote a specific alpha-1 blocker distinct from the broader class (doxazosin, terazosin). The pronunciation settled into /ˈpreɪ.zəˌsin/ in English-language pharmacology texts, with minor regional variations that preserve the final -sin phoneme, differentiating it from related agents with different stress patterns or suffixes. In sum, prazosin’s name reflects its chemical lineage, receptor-targeted mechanism, and its place within the late 20th-century pharmaceutical lexicon.
💡 Etymology tip: Understanding word origins can help you remember pronunciation patterns and recognize related words in the same language family.
Help others use "Prazosin" correctly by contributing grammar tips, common mistakes, and context guidance.
💡 These words have similar meanings to "Prazosin" and can often be used interchangeably.
🔄 These words have opposite meanings to "Prazosin" and show contrast in usage.
📚 Vocabulary tip: Learning synonyms and antonyms helps you understand nuanced differences in meaning and improves your word choice in speaking and writing.
Words that rhyme with "Prazosin"
-son sounds
Practice with these rhyming pairs to improve your pronunciation consistency:
🎵 Rhyme tip: Practicing with rhyming words helps you master similar sound patterns and improves your overall pronunciation accuracy.